SNTI icon

Senti Biosciences
SNTI

Overview Fund Activity

26 hedge funds and large institutions have $16.6M invested in Senti Biosciences in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 2 closing their positions.

Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
6
Reduced
10
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$727K
2
TM
2
Triatomic Management
California
$214K
3
BCM
3
Bridgeway Capital Management
Texas
$134K
4
State Street
4
State Street
Massachusetts
$55.1K
5
BlackRock
5
BlackRock
New York
$56.5K

Top Sellers

1
AG
1
Artal Group
Luxembourg
$78K
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$5.01M
3
KC
3
Kingfisher Capital
North Carolina
$0
4
AIM
4
ARK Investment Management
Florida
$2.72M
5
Morgan Stanley
5
Morgan Stanley
New York
$356K
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of America
26
Bank of America
North Carolina
$28 -$20K -1,430 -100%
KC
27
Kingfisher Capital
North Carolina
– -$248K -11,422 Closed
FIA
28
FNY Investment Advisers
New York
– -$7K -350 Closed
1
2